Alf Reime, chairman of the board, thanks Morten Tidemann and Hege Forus for their contributions to Resqunit Ab as board members since 2021 and says: "Both Morten and Hege have made significant contributions to Resqunit AB over the past years. I wish them all the best in their future endeavors".

Presentation of proposals for new board members:

Richard Wall chairm
Richard currently serves as Chairman of the Board in Nasdaq-listed Bio Vitos Pharma AB, a company specializing in hemolysis detection services. With a solid background in military cadet training and business administration, Richard has held significant management roles in the service industry, overseeing over 500 employees. His extensive experience includes leadership positions such as Sales Manager at Ahlsell and CEO of Wallmega AB, a company he founded. Additionally, Richard holds board memberships in Wall Group AB, Wiam Holding AB, and Målerimästarna Stockholm AB. Richard is independent in relation to the Company and the Group management. Independent in relation to the Company's major shareholders.

Jesper Carlsöö
Jesper will bring extensive experience in project development, currently serving as the Head of Project Development and Leasing at Logistea AB. With a distinguished career spanning over 16 years, including key roles at Corem Property Group, Jesper has consistently demonstrated his expertise and leadership. Jesper is independent in relation to the Company and the Group management. Independent in relation to the Company's major shareholders.

-

Having Richard Wall and Jesper Carlsöö on the board of RESQUNIT AB is highly advantageous due to Richard's experience with a Nasdaq-listed company and his extensive management background, along with Jesper's proven leadership, ensuring a strong, independent, and strategic governance to support the company's continued growth.

The full invitation to annual general meeting can be found here: https://news.cision.com/se/resqunit-ab/r/kallelse-till-arsstamma-i-resqunit-ab--publ-,c3991377